Nissay Capital Overview

  • Investor Type
  • Venture Capital
  • Status
  • Active
  • Investments
  • 215
  • Portfolio
  • 127
  • Exits
  • 60
Exits

Nissay Capital General Information

Description

Nissay Capital is a venture capital firm wholly owned by Japan's largest life insurance business, Nippon Life Insurance Company. Nissay Capital seeks to invest in early and growth stage businesses across multiple sectors and markets. Nissay has invested in over 1,200 unlisted companies with a total of 226 IPOs achieved since its inception in 1991.

Contact Information

Year Founded
1991
Investor Status
Actively Seeking New Investments
Trade Association
Principles for Responsible Investment (PRI)
Primary Investor Type
Venture Capital
Primary Office
  • 8th Floor, Nissay Nagatacho Building
  • 2-4-8 Nagatacho Chiyoda-ku
  • Tokyo, 100-0014
  • Japan
+81 00-0000-0000

Nissay Capital Investments (215)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Bulk Homme 11-Sep-2020 Later Stage VC 000.00 Personal Products Generating Revenue
000000 00 00000 14-May-2020 00000 00000 00.000 Food Products Generating Revenue
00000 10-May-2020 00000 00000 00.000 Other Healthcare Technology Systems Generating Revenue
000000 23-Jan-2020 00000 00000 00000 Information Services (B2C) Generating Revenue
0000 (0000 0000000 02-Dec-2019 00000 00000 00.000 Food Products Generating Revenue
000000000 22-Nov-2019 00000 00000 000.00 Drug Discovery Generating Revenue
00000000000 30-Oct-2019 00000 00000 00.000 Horticulture Generating Revenue 0000000 000000
0000 & 0000000 30-Sep-2019 00000 00000 000.00 Consumer Finance Generating Revenue
Tribeau 08-Aug-2019 Early Stage VC 00.000 Information Services (B2C) Generating Revenue
Handii 25-Jun-2019 Seed Round 00.000 Other Financial Services Generating Revenue
You’re viewing 10 of 215 investments. Get the full list »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Nissay Capital Exits (60)

Company Name Exit Date Exit Type Exit Size
Kringle Pharma 28-Dec-2020 IPO 00.000
00000 11-Nov-2020 000 00 00000000
00000 24-Jun-2020 000
00000 000 0000 18-Dec-2019 000
000000 (00000 0000 12-Dec-2019 000 00000
0000000 02-Dec-2019 000 00 00000000
0000000 000000 01-Nov-2019 000 00 00000000
000000 19-Jun-2019 000 00000
Creo Bioscience 01-Jun-2019 Out of Business
Makey 04-Mar-2019 Merger/Acquisition
You’re viewing 10 of 60 exits. Get the full list »

Nissay Capital Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Nissay Capital Team (6)

Name Title Deals Funds Boards Office
Arima Eiji President & Representative Director 00 Tokyo, Japan
Tomoyuki Kasai Chief Venture Capitalist 0 0 Tokyo, Japan
Junichi Imoto Senior Venture Capitalist 0 0 Tokyo, Japan
Kensuke Matsuo Manager, Investment Department 0 Tokyo, Japan
Kenko Nagai Investment Manager 0 0 Tokyo, Japan
You’re viewing 5 of 6 team members. Get the full list »